Entasis Therapeutics to Participate in A.G.P.’s Virtual Healthcare Symposium
November 17, 2020 08:00 ET
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
Entasis Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Business Update
November 05, 2020 16:05 ET
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
Entasis Therapeutics Highlights Multiple Data Presentations at Virtual ID Week
October 14, 2020 08:00 ET
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
Entasis Therapeutics to Participate in Upcoming Healthcare Investor Conferences
September 10, 2020 08:00 ET
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
Entasis Therapeutics Announces $25 Million Private Placement
August 28, 2020 08:00 ET
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Aug. 28, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX) (“Entasis”), a clinical-stage biopharmaceutical company focused on the discovery and development...
Entasis Therapeutics Reports Second Quarter 2020 Financial Results and Business Update
August 06, 2020 16:05 ET
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
Entasis Therapeutics to Participate in Upcoming Healthcare Conferences
August 05, 2020 08:00 ET
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
Entasis Therapeutics Awarded Contract from National Institutes of Health
July 06, 2020 08:00 ET
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., July 06, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
Entasis Therapeutics to Participate in the BMO 2020 Prescriptions for Success Healthcare Conference
June 18, 2020 08:00 ET
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., June 18, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel...
Entasis Therapeutics Completes Closing of Second Tranche of $35M Private Placement with Innoviva
June 11, 2020 16:05 ET
|
Entasis Therapeutics Holdings Inc.
WALTHAM, Mass., June 11, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) (“Entasis”), a clinical-stage biopharmaceutical company focused on the discovery and development...